Show simple item record

dc.contributor.authorAlderson, Den_US
dc.contributor.authorNankivell, Men_US
dc.contributor.authorLangley, Ren_US
dc.contributor.authorCunningham, Den_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2018-02-20T15:19:12Z
dc.date.issued2017-11en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/29208395en_US
dc.identifierS1470-2045(17)30776-3en_US
dc.identifier.citationLancet Oncol, 2017, 18 (11), pp. e641 - ?en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1458
dc.identifier.eissn1474-5488en_US
dc.identifier.doi10.1016/S1470-2045(17)30776-3en_US
dc.format.extente641 - ?en_US
dc.languageengen_US
dc.language.isoengen_US
dc.subjectAdenocarcinomaen_US
dc.subjectEsophageal Neoplasmsen_US
dc.subjectHumansen_US
dc.subjectNeoadjuvant Therapyen_US
dc.titleNeoadjuvant chemotherapy in oesophageal adenocarcinoma - Authors' reply.en_US
dc.typeJournal Article
dcterms.dateAccepted2017-09-29en_US
rioxxterms.versionofrecord10.1016/S1470-2045(17)30776-3en_US
rioxxterms.licenseref.startdate2017-11en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfLancet Oncolen_US
pubs.issue11en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume18en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMedicine (RMH Smith Cunningham)en_US
dc.contributor.icrauthorCunningham, Daviden_US
dc.contributor.icrauthorMarsden,en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record